Zimmer Biomet Acquires Paragon 28 for $1.2 Billion

Zimmer Biomet Holdings, Inc. (ZBH) entered a merger agreement on January 28, 2025, to acquire medical device company Paragon 28, Inc. (FNA) for $1.2 billion.

Deal Structure:

Under the terms of the agreement, Zimmer Biomet will acquire all outstanding shares of common stock of Paragon 28 for an upfront payment of $13.00 per share in cash, representing a premium of 8.33% from the stock’s last close.

Please subscribe for free or login to your InsideArbitrage account to access this article.